Device closure of muscular ventricular septal defects using the Amplatzer muscular ventricular septal defect occluder: Immediate and mid-term results of a U.S. registry
Ralf J. Holzer,David T. Balzer,Qi-Ling Cao,Ken Lock,Ziyad M. Hijazi,Amplatzer Muscular Ventricular Septal Defect Investigators +5 more
351
TL;DR: The Amplatzer mVSD device (AGA Medical Corp.) offers excellent closure rates and low mortality when used to close congenital muscular VSDs.
read more
About: This article is published in Journal of the American College of Cardiology. The article was published on 07 Apr 2004. and is currently open access. The article focuses on the topics: Heart septal defect.
read more
Chat with Paper
AI Agents for this Paper
Find similar papers on Google Scholar, PubMed and Arxiv
Write a critical review of this paper
Analyze citations of this paper to find unaddressed research gaps
Citations
Perventricular device closure of a doubly committed juxtaarterial ventricular septal defect through a left parasternal approach: midterm follow-up results.
TL;DR: Perventricular device closure of a DCVSD through a left parasternal approach is feasible, safe, and efficacious in selected patients and permits easy defect crossing and accurate device positioning.
Simulation of Transcatheter Atrial and Ventricular Septal Defect Device Closure Within Three-Dimensional Echocardiography-Derived Heart Models on Screen and in Virtual Reality.
Hannah H. Nam,Christian Herz,Andras Lasso,Simon Drouin,Adriana Posada,Brian H. Morray,Michael L. O'Byrne,Beatriz Paniagua,Denise C. Joffe,Burkhard Mackensen,Lindsay S. Rogers,Gabor Fichtinger,Matthew A. Jolley +12 more
16
Transcatheter Closure of Atrial and Ventricular Septal Defects: JACC Focus Seminar.
TL;DR: In this article , the authors describe the current state of transcatheter closure of atrial septal defects (ASDs) and VSDs in children and adults, including patient selection, procedural approach, and outcomes.
16
Device closure of congenital ventricular septal defects.
TL;DR: A comprehensive review of percutaneous and perventricular (hybrid) device closure of each type of ventricular septal defect is presented.
15
Intraoperative Device Closure of Postinfarction Ventricular Septal Defects
Michael S. Lee,Rebecca Kozitza,Daniel W. Mudrick,Matthew L. Williams,Andrew J. Lodge,J. Kevin Harrison,Donald D. Glower +6 more
TL;DR: The novel technique of deploying Amplatzer VSD devices in the operating room under direct vision through a right atriotomy with and without aortotomy in 2 patients with large inferobasal VSDs after myocardial infarction is reported.
15
References
Transcatheter closure of ventricular septal defects.
TL;DR: Preliminary data indicate that transcatheter VSD closure is feasible in selected cases, and three congenital VSDs had absent or diminished shunts after umbrella closure.
484
Echocardiographic follow-up of atrial septal defect after catheter closure by double-umbrella device.
Christine Boutin,Norman N. Musewe,Jeffrey F. Smallhorn,John Dyck,T Kobayashi,Leland N. Benson +5 more
TL;DR: It is suggested that ongoing spontaneous resolution of residual shunting occurs after device insertion, and factors related to the defect or device could not predict eventual resolution of remnant shunting.
206
Perventricular device closure of muscular ventricular septal defects on the beating heart: technique and results.
TL;DR: Perventricular closure of multiple muscular ventricular septal defects is safe and effective and could become the treatment of choice for any infant with muscular Ventricle free wall defects or any child with muscular ventricle sePTal defect and associated cardiac defects.
177
Transcatheter closure of muscular ventricular septal defects with the amplatzer ventricular septal defect occluder: initial clinical applications in children.
TL;DR: This encouraging initial clinical success indicates that the AVSDO is a promising device for transcatheter closure of MVSDs in children, and further clinical trials and longer follow-up are needed before the widespread use of this technique can be recommended.
173
Transcatheter closure of single muscular ventricular septal defects using the Amplatzer muscular VSD occluder: Initial results and technical considerations
TL;DR: The Amplatzer MVSD occluder is a safe and effective device for closure of MVSDs up to 12 mm in diameter and further clinical trials with this device are underway.
172
Related Papers (5)
[...]